Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

GH : 94.42 (-8.42%)
OMCL : 39.56 (-1.74%)
PACB : 1.5800 (-1.86%)
ALGN : 181.26 (-4.61%)
QDEL : 21.19 (-5.74%)
PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings?

PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings?

PACB : 1.5800 (-1.86%)
5 Must-Read Analyst Questions From PacBio’s Q4 Earnings Call

5 Must-Read Analyst Questions From PacBio’s Q4 Earnings Call

PACB : 1.5800 (-1.86%)
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference 

MENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate...

PACB : 1.5800 (-1.86%)
1 Safe-and-Steady Stock with Impressive Fundamentals and 2 We Avoid

1 Safe-and-Steady Stock with Impressive Fundamentals and 2 We Avoid

PACB : 1.5800 (-1.86%)
BYD : 83.62 (-2.99%)
ADP : 205.73 (-4.08%)
PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears

PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears

PACB : 1.5800 (-1.86%)
PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025

PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025

PACB : 1.5800 (-1.86%)
Pacific Biosciences: Q4 Earnings Snapshot

Pacific Biosciences: Q4 Earnings Snapshot

PACB : 1.5800 (-1.86%)
PacBio Announces Fourth Quarter and Full Year 2025 Financial Results

MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2025. Fourth quarter and full year...

PACB : 1.5800 (-1.86%)
PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner

MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a global...

PACB : 1.5800 (-1.86%)

Barchart Exclusives

As Walmart Raises Its Dividend 5%, Should You Buy WMT Stock?
Walmart's latest dividend increase, Q4 revenue growth, and global e-commerce expansion confirm the business still earns its Dividend King status, but WMT has a high forward earnings multiple and a stock price already above the average analyst target. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar